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In eye development the tasks of tissue specification and cell proliferation are regulated, in part, by the Pax6 and Pax6(5a) proteins respectively.
In vertebrates, Pax6(5a) is generated as an alternately spliced isoform of Pax6. This stands in contrast to the fruit fly, Drosophila melanogaster,
which has two Pax6(5a) homologs that are encoded by the eyegone and twin of eyegone genes. In this report we set out to determine the respective
contributions that each gene makes to the development of the fly retina. Here we demonstrate that both eyg and toe encode transcriptional
repressors, are expressed in identical patterns but at significantly different levels. We further show, through a molecular dissection of both proteins,
that Eyg makes differential use of several domains when compared to Toe and that the number of repressor domains also differs between the two
Pax6(5a) homologs. We predict that these results will have implications for elucidating the functional differences between closely related members
of other Pax subclasses.
© 2008 Elsevier Inc. All rights reserved.Keywords: Pax6(5a); Eyegone; Twin of eyegone; Retina; Eye; DrosophilaIntroduction
Pax6 genes play an indispensable role in the development of
wide range of retinal systems. Mutations within Pax6 orthologs
lead to severe retinal abnormalities in humans, mice and flies
(Ton et al., 1991; Hill et al., 1991; Quiring et al., 1994). In
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doi:10.1016/j.ydbio.2007.12.037developmental program of non-retinal tissues thereby producing
an ectopically situated eye (Halder et al., 1995a). Furthermore,
the universal presence of Pax6 in all seeing animals examined so
far has underscored its importance in eye development and
sparked a rethinking of the evolutionary origins of the eye
(Halder et al., 1995b; Gehring, 2002, 2005). As a consequence
Pax6 has turned into one of the best-studied members of the
paired box (Pax) family of transcription factors (Gehring, 1996;
Gehring and Ikeo, 1999; Pichaud and Desplan, 2002).
Pax6, like all other Pax proteins, contains a PAIRED DNA
binding domain (PD) which itself is comprised of two
functionally separable helix–turn–helix motifs, the PAI and
the RED domains (Noll, 1993; Jun and Desplan, 1996). In
addition Pax6 contains a third nucleic acid recognition motif,
the homeodomain (HD). The composition and structure of Pax6
provides for considerable flexibility in its interactions with
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functionally independent DNA recognition domains. While
vertebrates have only a single Pax6 gene, the fruit fly, Droso-
phila melanogaster, contains two Pax6 orthologs eyeless (ey)
and twin of eyeless (toy). Both play central roles in the
specification of the retina (Quiring et al., 1994; Halder et al.,
1995a,b; Czerny et al., 1999).
Alternate splicing of vertebrate Pax6 leads to the production
of a second isoform, Pax6(5a). This isoform (1) lacks a
functional PAI domain; (2) binds to DNA through its RED and
HD; and (3) has a different PD binding specificity than canonical
Pax6 (Walther et al., 1991; Jaworski et al., 1997). In vertebrates
Pax6 and Pax6(5a) appear to play different roles in retinal
development. Pax6(5a) loss-of-function mutants have different
phenotypes than those of Pax6. Likewise, overexpression of
Pax6(5a) induces different developmental defects and patterns
of gene expression than Pax6 (Duncan et al., 2000a,b; Chauhan
et al., 2002a,b,c; Singh et al., 2002; Haubst et al., 2004).
Pax6(5a) is also found in Drosophila but, unlike vertebrates,
does not result from alternate splicing of Pax6 but rather is
encoded by two separate genes, eyegone (eyg) and twin of
eyegone (toe). These genes arose from a relatively recent
duplication event and together with vertebrate Pax6(5a)
represent a novel subclass of Pax genes (Jun et al., 1998;
Aldaz et al., 2003). Similar to vertebrates, Drosophila Pax6 and
Pax6(5a) appear to play different roles in eye development.
While ey and toy act primarily in retinal specification, the main
function of eyg is to promote cell proliferation (Dominguez et
al., 2004; Chao et al., 2004). Each isoform exerts its influence
on development through different transcriptional mechanisms:
Ey acts as an activator while Eyg has the unique property of
acting as a dedicated repressor (Punzo et al., 2001, 2004; Yao
and Sun, 2005).
The Pax6 genes in Drosophila do not play completely
redundant roles in development. There are some differences in
the expression patterns of the two genes (Quiring et al., 1994;
Czerny et al., 1999; Kammermeier et al., 2001). As a result ey
and toy loss and gain-of-function mutants have some significant
phenotypic differences (Kammermeier et al., 2001). Even within
the eye specification hierarchy toy appears to sit atop ey (Czerny
et al., 1999; Kronhamn et al., 2002). Interestingly, there are also
disparities between the abilities of the two genes to direct eye
formation in non-retinal tissues (Halder et al., 1995a; Czerny et
al., 1999; C. Salzer and J. Kumar unpublished data). Differences
in the activities of individual DNA recognition domains and
protein–protein interaction motifs account for these many
distinctions (B.M. Weasner and J. Kumar unpublished data).
Since the Drosophila genome encodes two Pax6(5a) genes
we set out to determine if there are disparities between the roles
that eyg and toe play in eye development. We will show that
eyg and toe are expressed in identical patterns in the eye but
eyg mRNAs account for the vast majority of Pax6(5a)
transcripts. A comparison of the effects that loss of each gene
has on eye development demonstrates that eyg and toe are
differentially required in the retina. We have gone on to show
that while Toe, like Eyg, is a transcriptional repressor, the
number of repressor domains is different. And finally, wedemonstrate that each Pax(5a) protein makes use of a unique
combination of domains during normal eye development and
extra eye field induction. Together, these results suggest that
although eyg and toe arose through a recent duplication event,
the two Pax6(5a) proteins likely play non-redundant roles in the
eye and exert their influence on retinal development through
differential use of combinations of protein domains.Materials and methods
Fly stocks, reagents and microscopy
The following stocks were used in this study: eyg[1], eyg[22-2], eyg[M3-12],
wg[W11]-GAL4, eyg-GAL422-2, tub-GAL4, ey-GAL4, GMR-GAL4, dpp-GAL4,
CD-Gal4, UAS-ey, UAS-toy, UAS-so, UAS-optix, UAS-eya, UAS-GFP, wg-
lacZ and an additional 220 GAL4 lines from the Bloomington Drosophila Stock
Center (details of these stocks are available upon request). The eyg-Gal422-2
(also referred to as EM458) carries a P[GawB] insertion 527 bp upstream of the
eyg transcript. It is homozygous viable and has no visible phenotype on its own
(Jang et al., 2003). CD-Gal4 drives expression mimicking eyg expression (LHW
and YHS, unpublished results). The following antibodies were used in this
study: rat anti-ELAV, mouse anti-Eyg (gift of Ntalia Azpiazu), IgG conjugated
Cy3. Adult eyes were prepared for scanning and light microscopy as essentially
described in Kumar et al., 1998. Developing imaginal discs, salivary glands and
embryos were prepared for light and confocal microscopy as essentially
described in Yao and Sun, 2005 and Jang et al., 2003.
Generation of eyg and toe protein variants
Schematic drawings of Eyg deletion, Toe deletion and Eyg/Toe chimeric
proteins are diagramed in Fig. 9. An alignment of the Eyg and Toe proteins,
along with a demarcation of the individual domains, is provided within the
Supplemental Data Section Fig. S1). Our full-length Eyg protein is 525 amino
acids in length and represents the shortest functional isoform. Each protein
domain was originally defined by Jun and Desplan, 1996. The N-terminal (NT)
region consists of residues 1–13, the PD domain consists of residues 14–104,
the B region contains residues 105–231, the HD domain contains residues 232–
291 and the C-terminal (CT) region contains residues 292–525. The N-terminal
deletion (Eyg ΔNT) contains amino acids 14–525, the paired domain deletion
construct (Eyg ΔNT+PD) contains amino acids 105–525, the B domain
deletion construct (EygΔB) contains amino acids 1–104 fused to residues 232–
525, the homeodomain deletion construct (Eyg ΔHD) contains amino acids 1–
231 fused to 292–525 and the C-terminal deletion construct (EygΔCT) contains
amino acids 1–291. In addition we made two multiple domain deletion
constructs. The combined N and C terminal deletion constructs (EygΔNT+CT)
contains amino acids 14–291 and the triple N terminal, B domain and C-
terminal deletion construct (Eyg ΔNT+B+CT) contains amino acids 14–104
fused to residues 232–291.
Our full-length TOE protein is 640 amino acids in length. The N-terminal
region consists of residues 1–142, the PD domain consists of residues 143–233,
the B region consists of 234–383, the HD domain consists of residues 384–443
and the C-terminal region consists of residues 444–640. The N-terminal deletion
(ToeΔNT) contains amino acids 143–640, the paired domain deletion construct
(Toe ΔNT+PD) contains amino acids 234–640, the B domain deletion
construct (Toe ΔB) contains amino acids 1–233 fused to residues 384–640, the
homeodomain deletion construct (Toe ΔHD) contains amino acids 1–383 fused
to 444–640 and the C-terminal deletion construct (Toe ΔCT) contains amino
acids 1–443. In addition we made two multiple domain deletion constructs. The
combined N and C terminal deletion constructs (ToeΔNT+CT) contains amino
acids 143–443 and the triple N terminal, B domain and C-terminal deletion
construct (Toe ΔNT+B+CT) contains amino acids 143–233 fused to residues
384–443.
Wemade a series of chimeric proteins in which single or multiple domains of
Eyg were replaced with the corresponding domains of Toe. The Eyg/Toe NT
chimera contains amino acids 1–142 of TOE fused to residues 14–525 of Eyg,
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acids 143–233 from Toe, the Eyg/Toe B chimera was generated by replacing the
B domain of Eyg with amino acids 234–383 of Toe, the Eyg/Toe HD chimera
was generated by replacing the HD of Eyg with amino acids 384–443 of Toe and
the Eyg/Toe CT chimera contains amino acids 1–291 of Eyg fused to residues
444–640 of Toe. The Eyg/Toe NT+CT chimera was generated by replacing the
NT and CT regions of Eyg with amino acids 1–142 and 444–640 of Toe while
the Eyg/Toe PD+HD chimera was generated by replacing the PD and HD of
Eyg with amino acids 143–233 and 384–443 of Toe.
With the exception of three constructs (Eyg ΔNT+PD, ΔHD and Eyg
ΔCT) each of the remaining deletion and chimeric constructs are new and novel
lines. The Eyg ΔNT+PD, Eyg ΔHD and Eyg ΔCT constructs, while
independently generated, are similar to those described in Yao and Sun, 2005.
The results reported here, using these lines, are in agreement with those in the
earlier report.
Real-time PCR
Total RNA was isolated from 50 third instar larval eye-antennal discs.
1 μg of total RNA was reverse transcribed using the First Strand cDNA
Synthesis Kit (Roche). 1 μl of the RT reaction was amplified using the SYBR
Green PCR Master Mix (Roche Diagnostics, Germany) according to its
manufacturer's instructions. mRNA was quantified using a LightCycler
(Roche Diagnostics, Germany). Thermocycling conditions were 95 °C for
10 min and 45 cycles of [95 °C/10 s; 60 °C/5 s; 72 °C/9 s]. Fluorescence was
detected at the end of the extension phase. Melting curve analyses were
performed at the end of the amplification to confirm the specificity of the
amplified products and lack of primer dimers. The expected lengths of
amplified products were verified in gel electrophoresis and sequenced.
Quantified PCR was performed using the eyg-specific primer set (5′-
AGGCAAGAGTTCAGGTGTGG-3′ and 5′-CAACGGCTGCTGAGGTG-3′)
and toe-specific primer set (5′-GGCCAGGGTGCAGGTT-3′ and 5′
TTGCTGGTGCTGTACGGATA-3′), respectively.
Absolute quantification of transcripts
Two stand curves for eyg and toe, respectively, were generated using serial
dilutions of a known amount of the corresponding cDNA. Plasmids containing
eyg cDNA and toe cDNAwere linearized. The copy number was estimated by
optical density according to the molar mass derived from the plasmid size.
Different dilutions were made to obtain 102, 103, 104, 105 and 106 copies in 1 μl.
All standards were amplified in duplicates. Target mRNA copy numbers were
calculated based on the standard curves generated by LightCycler software
Version 4.05. The same cDNA samples were examined in five independent
PCR. When comparing different cDNA samples, the fluorescence intensity was
normalized to ribosomal gene rp49. The primers for rp49 were 5′-
TACAGGCCCAAGATCGTGAA-3′ and 5′-ACGTTGTGC ACCAG-
GAACTT-3′.
toe miRNA generation
The 22 nucleotides (nt. 1464 to 1485) of the toe coding sequence
(underlined in oligo 1 and 2) were selected as a target sequence. To generate
the toemiRNAi construct, the below four long primers were synthesized. The
PCR product of oligo 1 and 2 was amplified using oligos 3 and 4. The final PCR
product was digested with EcoRI and NotI and then cloned into pUAST.
[GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGAAGCAGC-
CATATCCGTACCGCTAAGTTAATATACCATATC] — oligonucleotide 1
[AATAATGATGTTAGGCACTTTAGGTACGAAGCAGCCATATCCG-






nucleotide 4In situ hybridization
Staged embryos and third instar larvae were prepared for in situ
hybridization (detailed protocols are available upon request). Non-radioactive
labeled antisense RNA probes were used for in situ hybridization (Tautz and
Pfeifle, 1989). The pBluescript-SKII-lune plasmid was linearized and
transcribed to generate eyg antisense RNA probes (Jun et al., 1998). The EST
clone, pOT2a-toe was similarly transcribed to synthesize the toe antisense RNA
probe. Both probes were denatured and hybridized to either embryos or imaginal
discs. All hybridizations and washes were done at 65 °C. Specific details of the
RNA probes and hybridization conditions are available upon request.Results
Expression of eyg and toe during development
eyg transcripts are distributed within several embryonic
tissues as well as the leg, wing and eye-antennal imaginal discs
(Jones et al., 1998; Jun et al., 1998; Aldaz et al., 2003). Here we
have characterized the expression pattern of toe and compare it
to that of eyg (Fig. 1). eyg and toe transcripts are first detected
in stage 9 embryos within the salivary gland precursor (SGP)
and a small cluster of cells within the dorsal head (Figs. 1A–C;
Jones et al., 1998; Jun et al., 1998). The expression of toe
transcripts in the SGP will persist through the rest of embryonic
and larval development while eyg expression is terminated in
late stage embryos and reinitiated later (Figs. 1D–I, Figs. 2J, K,
Jones et al., 1998). By late stage 10 both transcripts are also
found in identical patterns within the posterior spiracle (PS) and
within a cluster of cells at the anterior edge of each thoracic and
abdominal segment (Figs. 1D–F, Jones et al., 1998; Jun et al.,
1998). Expression of eyg and toe expands to the larval antennal
organ (AO) as well as the leg disc primordia by stage 12 (Figs.
1G–I, Jones et al., 1998; Jun et al., 1998). During the latter
stages of embryogenesis both eyg and toe transcripts accumu-
late in the presumptive eye-antennal imaginal disc (Figs. 1J–L;
Jones et al., 1998; Jun et al., 1998). Only two other members of
the eye specification cascade, ey and toy, share this expression
pattern (Quiring et al., 1994; Czerny et al., 1999). The
remaining members are added sequentially during the larval
development (Kumar and Moses, 2001). The only discernable
difference between the expression patterns of either Pax6(5a)
gene during embryogenesis is found within the SG: eyg
expression is eliminated while toe transcriptional levels are
maintained (Figs. 1J–L; Jones et al., 1998).
Within the developing larval eye-antennal discs both eyg and
toe transcripts accumulate in identical patterns. Within the
antennal segment both transcripts localize to the medial and
distal segments while in the eye disc expression of both genes is
found anterior to the morphogenetic furrow (Figs. 2A–C,
Dominguez et al., 2004). Unlike the similarities found in the
embryo, eyg and toe expression is somewhat different from that
of ey and toy. The Pax6 transcripts are expressed broadly ahead
of the advancing furrow (Quiring et al., 1994; Czerny et al.,
1999). However, eyg and toe expression is restricted to a
narrow domain of cells that straddle the dorsal–ventral
compartment boundary and does not extend laterally (Figs.
2A–C, Dominguez et al., 2004). This difference in expression is
Fig. 1. eyg and toe are expressed in nearly identical patterns during embryogenesis. Transcriptional profile of eyg and toe during several stages of embryogenesis.
Probes are listed at the top of each column. Embryonic stage is denoted at the right of each row. Note that the expression patterns are nearly identical except for the
salivary glands in stage 15 embryos. SGP=salivary gland precursor, PS=posterior spiracle, AO=antennal organ, SG=salivary gland. Anterior is to the left.
538 J.-G. Yao et al. / Developmental Biology 315 (2008) 535–551likely due to the requirements of eyg (and possibly toe) in
Notch mediated control of cell proliferation at the organizing
center versus the role of ey and toy in tissue specification.
Within the developing wing primordium both transcripts are
expressed broadly within the notum and in two discrete regions
within the presumptive wing (Figs. 2D–F). It is interesting that
one of those areas is particularly susceptible to being
transformed into retinal tissue in response to forced expression
of ey (Fig. 2F, arrow). Both eyg and toe transcripts are also
found within identical patterns of the leg primordium (Figs.
2G–I) and the anterior duct cells of the salivary gland (Figs. 2J,
K; Jones et al., 1998). The results from this and other studies of
eyg and toe expression suggest at first glance that these genes
may play redundant roles within several developing tissues
including the compound eye. It is unlikely, however, that thesegenes play completely surplus roles (at least in the eye) as eyg
loss-of-function mutants show near complete loss of retinal
tissue and forced expression of toe is insufficient to restore eye
development to these flies (see below).
Quantitative contribution of eyg and toe mRNA transcripts
In order to further examine the contributions of eyg and toe
to the development of the eye we used real-time PCR to
measure the levels of each Pax6(5a) mRNA transcript in the
eye-antennal disc (Fig. 3). We measured the combined levels of
eyg and toe in normal eye-antennal imaginal discs and
compared it to discs in which we forcibly expressed a
microRNA that is predicted to target and reduce the levels of
toe mRNA transcripts. This method was employed because a
Fig. 2. eyg and toe are expressed in nearly identical patterns in salivary glands and imaginal discs. Transcriptional profile of eyg and toe during the third larval instar.
Probes are listed at the top of each column. Tissue type is denoted at the right of each row. Note that the expression patterns are nearly identical. Arrow in panel I marks
area of the wing disc in which ectopic eye development is supported by the expression of several retinal determination genes including ey.
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results indicate that the vast majority (approximately 87%) of
Pax6(5a) mRNAs are transcribed from the eyg locus (Fig. 3A).
A direct comparison of eyg and toe levels in wild type eye-
antennal discs confirms the unequal levels of Pax6(5a)
expression (Fig. 3B). This relationship is maintained autono-
mously in individual eye and antennal discs (Fig. 3C). Finally,
we set out to determine if the relative levels of toe are dependent
upon eyg expression. In both eyg loss-of-function mutants and
forced expression experiments the level of toe remained
constant suggesting that toe levels are regulated independently
of eyg (Fig. 3D). It appears that toe transcriptional regulation is
also independent of eyg in several other tissues including thedeveloping embryo and wing imaginal discs (Aldaz et al., 2003;
Jang et al., 2003).
An anti-Pax6(5a) antibody recognizes the PD of Eyg and Toe
An in vivo comparison of the roles played by the two Pax6
(5a) genes has been hampered by the lack of available
molecular markers for the distribution of Eyg and Toe proteins.
To overcome this obstacle we generated a polyclonal antibody
that recognizes full-length Eyg (data not shown). Since the
antibody recognized a region of the eye disc in which both eyg
and toe are expressed, and since both proteins share
considerable sequence similarity within the DNA binding
Fig. 3. eyg is expressed at a higher level than toe in eye-antennal disc. (A) Relative level of anti-Eyg/Toe immunostaining on third instar eye discs. The signal intensity
in wild type (n=12) is taken as 100%. The signal intensity when Toe is efficiently knockdown (eyg-Gal4 driving UAS-toe miR; n=7) is reduced to about 87%. (B–D)
Graphs depict the levels of eyg and toe in the developing eye and antenna as assayed by quantitative RT-PCR. White bars are eyg transcript level. Black bars are toe
transcript level. (B) RT-PCR from eye-antennal disc from late third instar (left two bars) and second instar (right two bars). (C) When the eye and antenna discs were
surgically separated, the eyg transcript is higher than toe in both eye and antennal discs. (D) Absolute eyg and toe transcript numbers were estimated from eye-antennal
discs. toe transcript level was not significantly affected when eyg is overexpressed (CD-Gal4 driving UAS-eyg), indicate that toe is not transcriptionally regulated by
eyg. eygM3-12 is a null mutation with a deletion beginning 23 bp upstream of eyg and extending 13 kb downstream of eyg transcription unit (Jang et al., 2003).
Although the toe transcriptional unit is not affected, it is not clear whether toe expression is affected by the deletion. There is no eye-antennal disc in eygM3-12 to
examine whether toe is affected. So we drove eyg expression by the CD-Gal4 in eygM3-12 to rescue the eye-antennal disc. In these rescued eye disc, toe transcript level
is not significantly different from that in the wild type disc. This result clearly demonstrate that the eygM3-12 mutation affects only eyg.
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antibody. We expressed toe along the A/P axis of the wing disc
using a dpp-GAL4 driver. Our antibody not only recognized
endogenous Eyg, which is found within the hinge region, but it
also recognized the exogenously added Toe protein along the
A/P axis (Figs. 4A, B). Thus the antibody we recovered
recognizes both Eyg and Toe and will be referred to as anti-
Pax6(5a).
The DNA binding domains of Eyg and Toe (PD and HD) are
likely epitopes for the anti-Pax6(5a) antibody as they share a
high degree of sequence similarity between the two proteins.
We set out to determine which one of these two domains theantibody recognizes. We expressed individual domains of the
Pax6(5a) proteins along the margins of the eye disc using an
enhancer of the wingless (wg) gene. The anti-Pax6(5a) antibody
was then used to detect the expressed protein segments. In
addition to the endogenous Pax6(5a) proteins, the antibody only
detected the exogenously added Eyg PD (Figs. 4C–F, arrows).
The antibody failed to recognize a mutant Eyg PD thus
confirming the specificity of anti-Pax6(5a) to the PD (Fig. 4G).
The Pax6(5a) PDs share 96% sequence similarity and the
antibody fails to recognize the remaining regions of Toe (Fig.
4H; data not shown). A mutated version of the Toe PD is also
not recognized by the antibody (Fig. 4H). Together, our results
Fig. 4. The Eyg/Toe antibody recognizes the PD of Eyg and Toe. (A, B) Wing discs. (C–I) Eye-antennal discs. Arrowhead in all panels denotes endogenous Pax6(5a)
expression in the wing and eye disc. Arrows in panels a and e indicate detection of exogenous Pax6(5a) protein. Genotype of each tissue is indicated in each panel.
Note that wgw11 enhancer drives expression in the lateral regions of the eye disc ahead of the morphogenetic furrow. Anterior is to the right.
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As the anti-Pax6(5a) antibody recognizes both proteins we
generated tagged proteins in which full-length Eyg and Toe are
marked with the FLAG epitope tag in order to visualize each
protein individually. When UAS-Eyg[flag] is combined with an
eyg-GAL4 driver the distribution of the marked protein can be
followed in the imaginal discs and salivary glands (data not
shown). Unfortunately, as a toe-GAL4 line does not yet exist we
are unable to specifically follow the distribution of Toe.
However, combinatorial use of anti-Pax6(5a) with the Eyg
[flag] is sufficient to differentiate between the distribution
patterns of both proteins during normal and forced expression
experiments.
Differential requirement for eyg and toe in the eye and thorax
The absence of toe loss-of-function mutants has been
another obstacle to clearly defining the contributions that each
gene makes to retinal development. To complement the study of
existing eyg loss-of-function mutant phenotypes we made use
of a microRNA (miRNA) that targets toe mRNA transcript
thereby reducing Toe protein levels and potentially substitutingfor toe loss-of-function mutants. If the miRNA is co-expressed
with FLAG tagged version of either Pax6(5a) protein, only the
Toe levels are eliminated (Figs. 5A–F). Additionally, only
salivary gland defects that results from the overexpression of
Toe-Flag, are reversed by the miRNA (Figs. 5C, F). Eyg[flag]
levels remain unaffected (Figs. 5G–I). Furthermore, expression
of the miRNA in severe eyg mutants eliminates endogenous
Toe protein from both salivary glands and several imaginal discs
(Figs. 5J–O). Note that the images in M–O have been
overexposed to indicate that Toe protein cannot be detected in
the nucleus. Together, these results indicate that the miRNA
selectively targets toe transcripts.
We then set out to determine what contribution, if any, to eye
specification is made by toe. Using an eyg-GAL4 driver we
expressed 2 copies of the toe miRNA in regions of the
developing eye that normally express both Pax6(5a) proteins.
Interestingly, we did not observe any discernable defects
suggesting that although Toe levels are being eliminated in
the retina, the endogenous levels of Eyg is sufficient to fully
support eye development. The thorax, which also requires eyg,
is similarly unaffected by the expression of the miRNA under
control of either the eyg-GAL4 and/or tub-GAL4 (Figs. 6A, E).
Since eyg and toe mRNA levels make up 87% and 13% of Pax6
Fig. 5. An miRNA specifically knocked down Toe protein level. (A, D, G) eye-antennal discs. (B, E, H, J, M) wing discs. (C, F, I, K, N) salivary glands. (L, O) leg
discs. Genotypes of each tissue are indicated at the left of each row. Arrows in each panel indicate exogenous Toe or Eyg. Note that panels M–O have been
overexposed to show that there is Toe protein is down regulated (detected by anti-Flag in panels A–I, by anti-Eyg/Toe in panels J–O). Also note that the morphology of
the salivary gland is rescued when the toe miRNA is coexpressed with a full-length toe construct (panel F). The RED stain in panels A, D, G is Elav.
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heterozygous for an eyg null mutant. In this situation the eye
remains unaffected but the anterior–central region of the thorax
does not develop (a phenotype that is not observed in eyg
heterozygotes). This is visibly manifested as a severe groove
within the thorax (Figs. 6B, F). The failure to develop theanterior–central portions of the thorax is reminiscent of the
effect of severely diminished levels of eyg (Fig. 6G, Aldaz et
al., 2003). Interestingly, 50% reductions in Eyg protein levels
are not enough to severely alter the structure of the eye (Fig.
6C). However, if eyg and toe levels are simultaneously
compromised, then development of both the head and
Fig. 6. toe and eyg are differentially required in the developing eye and thorax. (A–D) adult eye and head. (E–G) adult thorax. Genotype of each tissue is indicated at
the top of each column. Arrow in panel D indicates the near complete inhibition of eye and head development. Arrows in panels F and G denote defects in thorax
development. Anterior is to the left.
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sensitive to simultaneous reductions in Eyg and Toe levels than
is the developing eye. Our results also suggest that removal of
toe, on its own, has little to no effect on the development of
either tissue. This is consistent with the minor contribution that
the toe locus makes to the overall levels of Pax6(5a) mRNA
(Fig. 3). These results suggest that Eyg and Toe proteins are
differentially required in the eye and thorax.
Consistent with this hypothesis, we have noted 43 different
situations in which expression of eyg and toe had differing
phenotypic consequences (Supplemental Data — Table 1). For
example, expression of eyg in the wing disc via a vg-GAL4
driver has no effect. However, expression of toe within the same
domain leads to increased levels of cell death. Conversely, while
expression of toe in the embryonic CNS and brain via the c768-
GAL4 driver has no effect, expression of eyg leads to
embryonic lethality. We have been able to exclude trivial
explanations such as line strength and protein levels as reason
for these disparities. Instead, our results further the contention
that the Pax6(5a) proteins are differentially required during
development. This contention is also supported by differential
effects on the developing eye and wing in response to the
expression of various Pax6(5a) deletion and chimeric proteins
(Fig. 9; Supplemental Data — Table 2).
Toe is transcriptional repressor
Using Eyg-VP16 (transcriptional activator) and Eyg-En
(transcriptional repressor) protein fusions, eyg has been shown
previously to encode a dedicated transcriptional repressor (Yao
and Sun, 2005). Based on the evolutionary relationship between
both Pax6(5a) genes, toe is also predicted to encode atranscriptional repressor. To test this hypothesis we created
transgenic flies that expressed full-length Toe fused to the VP16
activation domain (Toe-VP16) along the A/P axis of several
imaginal discs using a dpp-GAL4 driver. The activity of this
transcriptional-activating form of Toe failed to mimic the
activity of wild type Toe protein in several assays. In fact, in
certain instances Toe-VP16 appeared to induce dominant-
negative phenotypes. For instance, in contrast to Toe, which can
induce extra eye fields, the expression of the transcriptional-
activating form of Toe failed to promote and support eye
development in a forced expression assay (compare Figs. 7A to
10B). Second, Toe-VP16 induced the formation of abnormal
antennal structures and extra machrochaetes on the thorax,
which are likely dominant negative effects (Figs. 7B, C).
Another dominant-negative effect is seen when the expression
of Toe-VP16 in eyg hypomorphic mutants leads to the pro-
duction of “headless” flies (Figs. 7D, E). These phenotypes are
reminiscent of the effects observed when either the toe miRNA
or Eyg-VP16 is individually expressed within the same eyg
mutant background (Fig. 6D, Yao and Sun, 2005). It should be
noted that expression of the toe miRNA induced dominant
negative phenotypes, such as the production of headless flies,
only when the genetic background was compromised for eyg
function. As these animals are headless and die as pharate adults
we were unable to assay the effects that the toe miRNA had on
macrochaetes numbers and antennal structure. The induction of
dominant negative phenotypes by Toe-VP16 in an otherwise
wild type background is likely due to the strong activation of
putative Toe target genes via the VP16 activation domain. We
also expect that Toe-VP16 would also activate some Eyg targets
while the toemicroRNAwould only affect levels of Toe mRNA
and protein. This might also contribute to the stronger Toe-
Fig. 7. Toe is a transcriptional repressor. (A) Schematic of VP16 fusion assay. (B–E) adult eye, thorax, antenna and head. Genotypes of each tissue are indicated at the
top of each column. Arrows in panels C and D mark defects in thorax and antennal development. Anterior is to the left.
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that of Eyg-VP16 (Yao and Sun, 2005) our results are
suggestive that Toe, like Eyg, functions as a transcriptional
repressor.
Further evidence of Toe serving as a repressor comes from
the partial rescue of the eyg loss-of-function retinal phenotype
by expression of a chimeric protein in which Toe is fused to the
Engrailed repressor (Toe-EN, data not shown). It should be
noted that expression of Toe-EN failed to induce extra eye
fields along the ventral surface of the head. There are two
plausible explanations for these relatively mild effects. First,
the Toe-EN construct may not be expressed at high enough
levels to either fully rescue eyg mutants or induce extra eye
fields. We think that this is unlikely as the EN domain that is
fused to TOE is a strong transcriptional repressor and high
levels of the fusion protein are not predicted to be required in
this assay. Instead it may be that during normal development
Toe functions as a repressor on some target genes and as an
activator on others. Unlike Eyg, Toe may not function as a
dedicated repressor. Instead it may have multiple functions
with repression being one of its activities. This could account
for several of the observed difference in the activities of the
Pax6(5a) homologs (see below).
Mapping of the toe repressor domains
We set out to determine if the repressor domain(s) map to
similar locations within Eyg and Toe. It has been previously
demonstrated that Eyg contains two repressor domains: one
maps to the CT region, the other is located in either the NT or
the B regions of the protein (Yao and Sun, 2005; Figs. 8B–D).
Expression of Eyg ΔB anterior to the furrow using an ey-
GAL4 has a dominant negative effect on eye development
(data not shown). Often times these dominant negative effectscan be attributed to the deletion of either an activation or
repressor domain. Here we show that the repressor domain
within Toe is not located within the CT tail and may reside
within the NT and B domains. The assay used by Yao and Sun
and here is a bipartite system. In one half of the system a
chimeric protein in which the GAL4 DNA binding domain is
fused to either a full-length Pax6(5a) protein or an individual
domain is expressed along the margins of the eye under the
control of a wingless (wg) enhancer element. In the second
half of the system the same wg enhancer directs the expression
of a GFP reporter. A cluster of UAS sites separates the
enhancer element from the reporter (Fig. 8A). In flies lacking
the driver construct, GFP is expressed along the margins of the
eye field (Fig. 8B). When a portion of Eyg containing a strong
repressor (Eyg CT) is expressed in the same pattern,
expression of the reporter is completely lost (Fig. 8C). If a
weak or moderate repressor domain (Eyg ! CT mPDHD) is
expressed then a reduction in reporter activity is observed (Fig.
8D). If now we express just the CT of Toe along the margins
we see normal levels of the GFP reporter indicating that this
domain does not contain any repressor activity (Fig. 8E).
However, if the N-terminal portion of Toe containing mutated
PD and HDs is expressed then strong repression of the reporter
is seen. The most likely explanation is that a strong repressor
domain resides within either the NT or the B domains (Fig.
8F). Thus it appears that a major functional difference between
the Eyg and Toe proteins is the number and location of the
repressor domains.
Molecular dissection of Eyg and Toe during normal
development
As Eyg and Toe are derived from the same ancestral gene, are
expressed in identical patterns and function as transcriptional
Fig. 8. Toe repressor activity resides in its N-terminal portion. (A) Schematic of repressor assay. (B–D) Third instar eye-antennal discs accompanied by schematic of
driver/responder combinations. Note that wg-GAL4 drives expression in the lateral margins ahead of the morphogenetic furrow. Anterior is to the right.
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development, we conducted a molecular dissection of both
proteins in an effort to understand the biochemical basis that
underlies these unique functions. These experiments which are
aimed at elucidating the differences between two Pax6(5a)
proteins (Eyg and Toe) extend those of Yao and Sun, 2005
which focused on the functional differences between the
activities of Eyg and Pax6 (Ey). An alignment of the Eyg and
Toe proteins, along with a demarcation of the individual
domains, is provided within the Supplemental Data Section.
The reagents that we generated for our studies include a series
of protein deletions in which individual or multiple domains of
either Eyg or Toe were removed. These Pax6(5a) variantswere used to test the functional requirements for each domain.
We also generated a series of chimeric Pax6(5a) proteins in
which single or multiple domains of Eyg were deleted and
replaced with the corresponding regions of Toe. These
chimeric proteins were used to test the degree to which each
domain has been functionally conserved. Diagrams of the
Pax6(5a) deletions and chimeras are depicted in Figs. 9A–C.
Each variant was assayed for the ability to rescue an eyg[1]
loss-of-function mutant (Figs. 9 and 10) and to induce extra
eye fields within ventral head segments (Figs. 9 and 11). It
should be noted that for each deletion and chimera we tested
multiple UAS insertion lines and conducted our experiments at
several temperatures. We did this in an attempt to eliminate the
Fig. 9. Functional assay of domains in Eyg and Toe. (A–C) Schematic of Eyg deletions, Toe deletions and Eyg/Toe chimeric proteins. (D) Summary of Eyg and Toe
domain requirements in rescue and overexpression assays. (E) Summary of results from rescue of eyg loss-of-function mutants and extra eye field induction assays.
546 J.-G. Yao et al. / Developmental Biology 315 (2008) 535–551possibility that our results are affected by expression levels or
insert integrity. We also crossed each construct to several
GAL4 lines to ensure that each deletion or chimeric protein
was functional.
Both wild type and all variants of Eyg and Toe were
expressed in eyg[1] homozygous mutant retinas, which contain
between 40 and 50 ommatidia (Fig. 10A). Flies that are
homozygous for eyg null alleles die during embryogenesis and
are therefore not appropriate for this particular assay. Expres-
sion of wild type Eyg but not Toe is sufficient to return eyg[1]
mutant retinas to near wild type structure suggesting that these
genes have functionally diverged since the duplication (Figs.
9D and 10B, C). These genes are thus unlikely to play redun-
dant roles in eye development.Requirements for the non-DNA-binding domains in normal eye
development
We first proceeded to test the functional requirements of the
non-DNA-binding domain. We started with deleting the
sequences that lie upstream of the RED DNA binding domain
in both proteins (Eyg ΔNT, Toe ΔNT). Toe ΔNT, but not Eyg
ΔNT, restored eye development to eyg[1] mutant retinas (Figs.
9D and 10D, E) suggesting that not only is there a functional
requirement for the NT region of both proteins but also that this
region may functional distinguish the two Pax6(5a) proteins
from each other. Surprisingly, expression of the Eyg/Toe NT
chimera is also capable of rescuing eyg[1] (Figs. 9D and 10F).
This result indicates that while the NT domain may functionally
Fig. 10. Rescue of eyg1 loss-of-function mutants by expression of Eyg and Toe protein variants. Scanning electron micrographs of adult compound eyes. Genotypes of
each animal are listed within each panel. All UAS lines were expressed using an ey-GAL4 driver. Anterior is to the right.
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context dependent. Eyg contains two repressor domains, of
which one lies within the first 443 amino acids of the protein
(Yao and Sun, 2005). This region includes the NT, PD, B and
HD as shown in Fig. 9A. Mutational analysis excluded the PD
and HD regions thus leaving either the NT or B regions as
possible sites for the repressor activity of Eyg. Our results raise
the possibility that the repressor activity of Eyg resides within
the NT region.
We then looked at the requirements for the B domain, a stretch
of amino acids that lies between the PD and HD DNA binding
motifs but is yet to be assigned a role in Pax protein function.
Forced expression of constructs in which the B regions from Eyg
and Toe were deleted individually or in combination with the
NT and CT regions (Eyg ΔB, Toe ! B, Eyg ΔNT+B+CT, Toe
ΔNT+B+CT) had a dominant negative effect on eyg[1] flies;
the heads were severely deformed, the retinas were not restored
to wild type and the flies died in their pupal cases (Figs. 9D and
10J–K, V, X). In contrast, eyg[1] mutant retinas were restored
to near wild type levels when region B of Eyg was replaced
with homologous region from Toe (Eyg/Toe B; Figs. 9D and
10L). These results suggest that the B domain is functionallyessential for Pax6(5a) activity and has been functionally
conserved between the two transcription factors. This conclu-
sion is supported by the observation, from a related set of
experiments in which the Pax6 proteins Ey and Toy do not
function normally in the absence of the B domain. Proteins
lacking this domain produce ectopic eyes that are less frequently
observed and are significantly smaller in size than those
produced by the full-length proteins (B.M. Weasner and J.P.
Kumar, unpublished data). There is the possibility, however, that
region B simply acts as a linker or spacer for the two DNA
binding motifs and that deleting this region from any Pax protein
may disrupt the normal structural configuration as the RED and
HD motifs are brought together. One could interpret the rescue
of eyg[1] by Eyg/Toe B as simply the result of restoring the
spacing between the DNA binding motifs. We think that is rather
unlikely as a similar chimera in which the B domains of EYand
TOY have been interchanged appear to have acquired new
activities and do not simply function as the parental Pax6 protein
(B.M. Weasner and J.P. Kumar, unpublished data).
The C-terminal tail (residues 3′ of the HD) of Eyg but not
Toe contains a transcriptional repressor domain (Yao and Sun,
2005; this report). We deleted the CT region in an attempt to
Fig. 11. Induction of extra eye fields by the expression of Eyg and Toe variants. Scanning electron micrographs of adult compound eyes and extra eye fields. Genotypes
of each animal are listed within each panel. All UAS lines were expressed using a dpp-GAL4 driver. Yellow arrow in panel A indicates position of extra eye field.
Anterior is to the right.
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Pax6(5a) protein from the other. Expression of Eyg ΔCT and
Toe ΔCT fully restored eye development to eyg[1] mutant
retinas (Yao and Sun, 2005; Figs. 9D and 10P, Q). While these
results suggest that the CT is dispensable for Eyg function, it
appears that the CT region is required for Toe activity. In fact,
the results also suggest that there is a combinatorial interaction
between the Toe NT and CT regions as the presence of both
domains prevents Toe from rescuing the eyg mutants. Removal
of either the NT or the CT is sufficient to then allow for rescue.
These results are also intriguing as they suggest that the
repressor domain within the CT of Eyg is not essential for its
normal activity. Rather, it seems that the second repressor site,
which is located in either the NT or B regions of the protein, is
more essential to Eyg function. There appears, however, to be a
genetic interaction between the NT and CT regions of both
proteins. Expression of either Eyg ! NT+CT or Toe ΔNT+CT
was insufficient to support eye development in eyg[1] mutants
(Figs. 9D and 10S, T). This is in contrast to the near full rescue
of eyg[1] retinas that is observed when either NT or CT regions
of Toe are individually removed (Figs. 9D and 10E, Q). Such
interactions are also evidenced by the inability of Eyg/Toe NT+
CT to rescue eyg[1] flies when expression of chimeras involving
individual domains (Eyg/Toe NT, Eyg/Toe CT) is sufficient to
restore eye development (Figs. 9D and 10F, R, U).
Requirements of the RED and homeobox DNA binding
domains in normal eye development
We were also interested in determining if functional
distinctions between Eyg and Toe could be accounted for bydifferences in the use and requirements of the RED and HD
motifs. Eye development could be restored to eyg[1] mutants
through expression of Pax6(5a) variants that in which the RED
domain was interchanged but not deleted (Yao and Sun, 2005;
Figs. 9D and 10G–I). These results suggest that both Eyg and
Toe exert their influence on transcription through the RED
domain and that these domains have been functionally
conserved. We similarly deleted and substituted the HDs and
observed that expression of EYG ΔHD and Eyg/Toe HD
rescued the small eye phenotype of eyg[1] mutants while Toe
ΔHD failed in this respect (Yao and Sun, 2005; Figs. 9D and
10M–O). These results indicate that in contrast to absolute
requirement for the RED domain it appears that the Eyg HD is
completely dispensable for eye development. As a consequence
Eyg primarily uses its RED domain to interact with DNA.
There are several precedents for this observation. Several Pax
genes including Drosophila pox meso and mammalian Pax1
and Pax9 completely lack the HD (Noll, 1993; Mansouri et al.,
1999). Second, during eye development the HD of EY/Pax6 is
also dispensable as an EY protein lacking the HD is sufficient
to rescue loss-of-function ey mutants (Punzo et al., 2004).
These results do not speak to the requirements of the Toe HD
since the Toe full-length protein also failed to rescue. However,
data presented below on the generation of extra eye fields
indicates that Toe also does not make use of the HD (see
below).
A large body of evidence indicates that a considerable
degree of flexibility exists for the combinatorial use of DNA
binding motifs by Pax proteins. We attempted to test the
extreme limits of this feature by simultaneously replacing
both the RED and HD regions of Eyg with the corresponding
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HD chimera rescued the structural defects of eyg[1] mutants
(Figs. 9D and 10X). This result provides further evidence that
the contextual framework motifs provided by the remaining
non-DNA binding regions can influence how certain
combinations of DNA binding domains are used during
development.
Domain requirements for extra eye field induction
We set out to determine if Toe, like Eyg, is only capable
of inducing extra eye fields adjacent to the developing
endogenous retinal epithelium (as opposed to ectopic eye
formation in other non-retinal tissues). We expressed each
Pax6(5a) gene within 219 different developmental patterns
and looked for the presence of retinal tissue. In the case of
the full-length Eyg and Toe proteins, we were only able to
induce extra eye fields adjacent to the normal compound eye
(Figs. 11A, B; Jang et al., 2003). We were interested in
determining if the domain requirements for the generation of
extra eye fields are the same as those needed for the
promotion of normal eye development. There is a precedent
for the two processes requiring different protein domains. The
activity of the CT regions of the SIX family proteins Sine
Oculis and Optix (results of an ancient duplication) is an
example. These regions are not interchangeable during
normal eye development and in fact are thought to confer,
in part, functional specificity upon SIX proteins. However,
this is not the case for ectopic eye generation. The CT
domains are in fact interchangeable under these conditions
(Weasner et al., 2007). This result suggests that there are
different molecular and biochemical requirements for normal
and ectopic eye formation.
Of all the deletion constructs only the Toe ΔHD, in which
the HD has been deleted, is capable of promoting the formation
of an extra eye field (Fig. 11C). This implies that each domain
of Eyg and all but the HD of Toe are required. This stands in
contrast to our rescue assays in which the HD and CT regions of
Eyg are dispensable for normal eye formation (Figs. 10M, P).
Other differences were observed when the chimeric proteins
were used to induce extra eye fields. In these cases the NT, B
and PD domains can be individually substituted. Certain
domain combinations (Eyg/Toe NT+CT and the Eyg/Toe PD
+HD) could also be substituted successfully (Figs. 11D–H).
Again, these requirements are dissimilar from those needed for
Eyg and Toe to function properly during normal eye
development. Our rescue assays concluded that all individual
domains and only the PD+HD combination could be
exchanged and still rescue eyg[1] mutants (Figs. 10F, I, L, O,
R, X). As mentioned earlier, similar differences in domain
requirements during normal eye development and ectopic eye
formation (or extra eye field generation) are observed with other
eye specification genes. These apparent disparities may reflect
actual differences in the protein–protein interactions that occur
between eye specification proteins and their cofactors. Such a
model might imply that there is some flexibility in the path to
producing an eye.Discussion
In eye development the tasks of tissue specification and cell
proliferation are regulated, in part, by the Pax6 and Pax6(5a)
proteins respectively. In vertebrates, Pax6(5a) is generated as
an alternately spliced isoform of Pax6. However, in Droso-
phila Pax6(5a) homologs are encoded by the eyegone and twin
of eyegone genes. In this report we sought to determine the
respective contributions that each gene makes to the
specification of the fly. An initial analysis of transcriptional
patterns indicates that both Pax6(5a) genes are expressed in
identical patterns within the retina. However, eyg is expressed
at a much higher level than toe. Not surprisingly, while
mutations in eyg nearly delete the eye, a reduction in toe via
miRNA treatments has no effects on its own. Simultaneous
reductions in both genes, in contrast, result in a “headless”
phenotype. Using a set of mini genetic screens and activator/
repressor fusion assays we also demonstrated that both proteins
function as transcriptional repressors. In total, these character-
istics suggest that eyg and toe might play redundant roles in
during development.
However, the high level of sequence divergence within the
non-DNA binding domains hints that their functions may only
be partially redundant. We set out to molecularly dissect both
Pax6(5a) proteins and determine what, if any, differences exist
between the activities of each protein. In two experimental
contexts we were able to demonstrate that such differences
between eyg and toe exist. First, a comparison of eyg and toe
loss-of-function phenotypes indicated that toe played a greater
role in the development of the thorax than the eye. Second,
forced expression of both full-length proteins throughout the
developing fly identified 43 different instances in which
expression of one Pax6(5a) gene induced a different phenotype
than the other. Taken together, these results hint that the roles of
eyg and toe may be not be completely redundant.
We then set to determine which domain(s) might account
for the differences seen in loss-of-function mutants and forced
expression assays. We generated a set of deletion and chimeric
proteins to dissect the requirement for each domain as well as
the level of functional conservation. We attempted to rescue
eyg1 mutants as well as generate extra eye fields with these
protein variants. Our results indicate that Eyg and Toe make
differential use of several domains. Many of these differences
map to the non-DNA binding domains. We have also
demonstrated that one possible mechanism for this is that
Toe has only one repressor domain, while Eyg has two. Our
prediction is that the differences in the non-DNA binding
domains are the primary determinants of how each Pax6(5a)
protein will influence development. It is less likely that the
two DNA binding domains functionally distinguish one
protein from another as there is an extremely high level of
sequence conservation within these motifs. Thus our model
for how Eyg and Toe Function is that both transcription
factors bind to similar target genes but can differentially
influence transcription through differing levels of repressor
activity and/or interactions with disparate binding partners
(Figs. 12A, B).
Fig. 12. Putative models for Pax6(5a) activity and structure of Pax subclasses. (A, B) Putative models. In model A the difference in the strength of repression is due to
the interaction of Eyg and Toe with different binding partners. In model B these strength differences are simply due to different protein levels (binding partner is the
same in this model). Note that the relative strength of repression can vary between the eye and thorax. (C) Table of mammalian Pax genes with a list of putative
domains. PD=paired domain, HD=homeodomain, OP=octapeptide, HD1–3 refers to the three alpha helices.
550 J.-G. Yao et al. / Developmental Biology 315 (2008) 535–551These results may have broad implications for the activities
of other Pax genes in both Drosophila and vertebrates. The fly
genome contains two Pax6 genes, eyeless (ey) and twin of
eyeless (toy), both of which also arose through a relatively recent
duplication. Both share high degrees of homology within the
DNA binding domains while having significantly lower levels
of sequence conservation in the non-DNA binding regions (R.
Datta and J.P. Kumar, unpublished data). Functionally, Ey and
Toy have differing abilities to induce eye formation when
expressed in non-retinal tissues (Halder et al., 1995a,b; Czerny
et al., 1999). Some of these differences have been attributed to
the C-terminal tail section of each protein (Punzo et al., 2004).
Mammalian Pax genes are grouped, in part, according to
their structure (Fig. 12C). Individual classes are defined by the
presence or absence of the octapeptide and the two DNA
recognition (Paired and Homeobox) motifs. Like the fly genes,
members within each Pax subclass share a very high degree of
sequence conservation within the DNA binding domains thus
they are likely to bind to very similar targets. Our results, if
extended to these other Pax genes, would suggest that their
activity could be distinguished by examining the localization
of activation and repressor domains as well as the use of
different binding partners.
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